Moriarty John B sold RNAM
February 27, 2026 · Form 4 insider transaction
Moriarty John B sold 92,054 shares of RNAM, a transaction worth N/A. The trade was recorded as disposition to the issuer and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Disposed (sell-side)
Shares
92,054
Price
N/A
Total value
N/A
InsiderMoriarty John B
RoleOfficer
CompanyRNAM
SecurityCommon Stock
Transaction codeD: Disposition to the issuer
Transaction dateFebruary 27, 2026
Filing dateFebruary 27, 2026
Shares owned after0
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The reported securities represent shares of Common Stock (inclusive of shares of Common Stock issuable upon settlement of previously reported restricted stock units) disposed of pursuant to the terms of the Agreement and Plan of Merger, dated as of October 25, 2025 (the "Merger Agreement"), among Novartis AG ("Novartis"), Ajax Acquisition Sub, Inc., an indirect wholly owned subsidiary of Novartis, and the Issuer.